Contact this trialFirst, we need to learn more about you.
Sphingosine-1-Phosphate Receptor Modulator
Etrasimod for Eczema
Recruiting0 awardsPhase 2 & 3
Saint Petersburg, Florida
This trial is testing a daily pill called etrasimod to treat adults with moderate to severe eczema who haven't had success with other treatments. The study will compare the effects of etrasimod to see if it is safe and effective. Participants will have periodic clinic visits to monitor their health and symptoms.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service